MBIO
Mustang Bio Inc
NASDAQ: MBIO · HEALTHCARE · BIOTECHNOLOGY
$0.75
-0.66% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2,205.73x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$10.00
+1235.11%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.72M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $-50000.00 |
| Net income | $-77.53M | $-51.60M | $-15.75M | $-1.92M | $-538000.00 |
| EPS | — | — | — | — | $-0.39 |
| Free cash flow | $-68.14M | $-49.59M | $-11.41M | $-5.26M | $-1.72M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Mustang Bio Inc trades at $0.75. Our Smart Value Score of 26/100 indicates the stock is weak. TTM revenue stands at $-50000.00.
Frequently asked questions
What is Mustang Bio Inc's stock price?
Mustang Bio Inc (MBIO) trades at $0.75.
Is Mustang Bio Inc overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Mustang Bio Inc (MBIO)?
The analyst target price is $10.00, representing +1235.1% upside from the current price of $0.75.
What is Mustang Bio Inc's revenue?
TTM revenue is $-50000.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2,205.73x
ROE-67.90%
Beta2.18
50D MA$0.84
200D MA$1.25
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—